BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15953282)

  • 61. [Treatment of macroprolactinoma with cabergoline during pregnancy].
    Forsbach-Sánchez G; Tamez-Pérez HE; Hernández-Herrera R; Bafidis-Lechuga B
    Rev Med Inst Mex Seguro Soc; 2009; 47(3):307-10. PubMed ID: 20141661
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transsphenoidal treatment of secondary empty sella syndrome using low field strength intraoperative MRI: case report.
    Kubben PL; Cornips EM; Looij BJ; Beuls EA
    Minim Invasive Neurosurg; 2010 Aug; 53(4):198-202. PubMed ID: 21132613
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [A rare case of giant galactocele associated with prolactinoma].
    Tayae M; Jamor J
    Pan Afr Med J; 2017; 27():97. PubMed ID: 28819518
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Low-dose cabergoline causing valvular heart disease in a patient treated for prolactinoma.
    Cawood TJ; Bridgman P; Hunter L; Cole D
    Intern Med J; 2009 Apr; 39(4):266-7. PubMed ID: 19402868
    [No Abstract]   [Full Text] [Related]  

  • 65. [Capacities of chemotherapy for pituitary tumors].
    Vaks VV; Dedov II
    Zh Vopr Neirokhir Im N N Burdenko; 2005; (2):30-6; discussion 36-7. PubMed ID: 16078633
    [No Abstract]   [Full Text] [Related]  

  • 66. Pituitary apoplexy within a macroprolactinoma.
    Watt A; Pobereskin L; Vaidya B
    Nat Clin Pract Endocrinol Metab; 2008 Nov; 4(11):635-41. PubMed ID: 18797434
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Hyperprolactin as cause of hypoactive sexual desire in men].
    Baltzar MT; Anholm C; Petersen CD
    Ugeskr Laeger; 2012 Jun; 174(25):1745-6. PubMed ID: 22713225
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pathological gambling and hypersexuality in cabergoline-treated prolactinoma.
    Falhammar H; Yarker JY
    Med J Aust; 2009 Jan; 190(2):97. PubMed ID: 19236300
    [No Abstract]   [Full Text] [Related]  

  • 69. Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma.
    Bilbao I; Egaña N; García C; Olaizola I
    Endocrinol Diabetes Nutr; 2017 Dec; 64(10):564-566. PubMed ID: 29137963
    [No Abstract]   [Full Text] [Related]  

  • 70. Invasive giant prolactinoma with loss of therapeutic response to cabergoline: expression of angiogenic markers.
    Mallea-Gil MS; Cristina C; Perez-Millan MI; Villafañe AM; Ballarino C; Stalldecker G; Becu-Villalobos D
    Endocr Pathol; 2009; 20(1):35-40. PubMed ID: 19172414
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cabergoline-induced pneumocephalus in a medically treated macroprolactinoma.
    Machicado JD; Varghese JM; Orlander PR
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3412-3. PubMed ID: 22802088
    [No Abstract]   [Full Text] [Related]  

  • 72. Giant prolactinoma causing cranio-cervical junction instability: a case report.
    Zaben MJ; Harrisson SE; Mathad NV
    Br J Neurosurg; 2011 Dec; 25(6):754-6. PubMed ID: 21344972
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effectiveness of treating ovarian hyperstimulation syndrome with cabergoline in two patients with gonadotropin-producing pituitary adenomas.
    Knoepfelmacher M; Danilovic DL; Rosa Nasser RH; Mendonça BB
    Fertil Steril; 2006 Sep; 86(3):719.e15-8. PubMed ID: 16952513
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Osteopenia in children and adolescents with hyperprolactinemia.
    Galli-Tsinopoulou A; Nousia-Arvanitakis S; Mitsiakos G; Karamouzis M; Dimitriadis A
    J Pediatr Endocrinol Metab; 2000 Apr; 13(4):439-41. PubMed ID: 10777000
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ectopic Prolactinoma Presenting as Bacterial Meningitis: A Diagnostic Conundrum.
    Akinduro OO; Akinduro OT; Gupta V; Reimer R; Olomu O
    World Neurosurg; 2018 Apr; 112():227-231. PubMed ID: 29378345
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cabergoline-induced psychosis in a patient with undiagnosed depression.
    Bilal L; Ching C
    J Neuropsychiatry Clin Neurosci; 2012; 24(4):E54. PubMed ID: 23224490
    [No Abstract]   [Full Text] [Related]  

  • 77. Treating prolactinoma can prevent autoimmune diseases.
    Watad A; Versini M; Jeandel PY; Amital H; Shoenfeld Y
    Cell Immunol; 2015 Apr; 294(2):84-6. PubMed ID: 25468803
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Resolution of a hyperprolactinemia in a western lowland gorilla (Gorilla gorilla gorilla).
    Chatfield J; Zhang L; Ramey J; Bowsher T; Loskutoff N; O'Neill K
    J Zoo Wildl Med; 2006 Dec; 37(4):565-6. PubMed ID: 17315448
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A case of pediatric atypical prolactinoma: significance of a multidisciplinary treatment approach.
    Inoue A; Ohnishi T; Kohno S; Kitazawa R; Mizuno Y; Nishikawa M; Ohue S
    Clin Neurol Neurosurg; 2014 Sep; 124():138-41. PubMed ID: 25048518
    [No Abstract]   [Full Text] [Related]  

  • 80. Apoplexy of a microprolactinoma during pregnancy: case report and review of literature.
    Couture N; Aris-Jilwan N; Serri O
    Endocr Pract; 2012; 18(6):e147-50. PubMed ID: 22982795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.